ENTITY
Shanghai Junshi Biosciences

Shanghai Junshi Biosciences (1877 HK)

209
Analysis
Health CareChina
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Refresh
03 Dec 2018 10:11

Junshi Bioscience (君实医药) IPO: Thoughts on Valuation (Part 2)

Shanghai Junshi Biosciences, a China-based biotechnology company listed on the NEEQ market (ticker 833330.NEEQ) with a market capitalization of USD...

Logo
643 Views
Share
03 Dec 2018 08:00

Junshi Biosciences IPO Preview: A Sense of Déjà Vu Without the Excitement

Shanghai Junshi Bioscience Co. Ltd. (1387344D CH) is a biopharmaceutical company which is developing a pipeline of 13 biologic drugs, including...

Logo
407 Views
Share
bullishSoftbank Corp
01 Dec 2018 17:34

ECM Weekly (1 December 2018) - Softbank Corp, Tencent Music, Cansino, Wuxi Apptec, Fosun Tourism

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
12 Nov 2018 09:54

Junshi Bioscience (君实医药) IPO: Early in Application but Behind in Key Indications (Part 1)

Shanghai Junshi Biosciences, a China-based biotechnology company listed on the NEEQ market (ticker 833330.NEEQ) with a market capitalization of USD...

Logo
470 Views
Share
17 Sep 2023 10:10

A-H Premium Weekly (Sep 15th): Postal Savings, Sinopec Corp, Shanghai Fudan, Sinopec Oilfield

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Postal Savings, Sinopec Corp, Shanghai Fudan, Sinopec...

Logo
441 Views
Share
x